What is Zepbound?
Zepbound is tirzepatide approved for chronic weight management — currently the most effective FDA-approved weight loss medication available. Approved in November 2023, it added an obstructive sleep apnea indication in December 2024, another first.
Qualification mirrors Wegovy: BMI 30+, or 27+ with a weight-related condition. In the SURMOUNT-5 head-to-head trial, Zepbound beat Wegovy directly — 20.2% versus 13.7% average weight loss.
Lilly also sells Zepbound single-dose vials through LillyDirect at $349–$499/month cash-pay, undercutting typical branded pricing and squeezing the compounded market.
How it works
Zepbound activates both GIP and GLP-1 receptors — the dual incretin mechanism unique to tirzepatide. Appetite drops, fullness arrives faster and lasts longer, and the GIP component appears to enhance fat metabolism while easing GI side effects.
The result is the largest average weight loss ever recorded for an approved obesity medication, at rates previously seen only with bariatric surgery.
Dosing schedule
Zepbound titrates in 2.5 mg steps every 4+ weeks; 5, 10, and 15 mg are the labeled maintenance doses:
| Dose | When |
|---|---|
| 2.5 mg / week | Weeks 1–4 — starter dose |
| 5 mg / week | First maintenance dose |
| 7.5–10 mg / week | Step up if needed |
| 12.5–15 mg / week | Maximum range |
Results in clinical trials
SURMOUNT-1 delivered 22.5% average weight loss at 15 mg (efficacy estimand) — over 56 lbs for the average participant — with more than half losing 20%+. SURMOUNT-5 then beat Wegovy head-to-head, 20.2% vs 13.7%. For sleep apnea, Zepbound cut apnea events by roughly two-thirds in SURMOUNT-OSA.
Side effects
Common
- Nausea
- Diarrhea
- Constipation
- Vomiting
- Injection site reactions
- Fatigue
- Hair loss (reported)
Serious (rare)
- Pancreatitis
- Gallbladder disease
- Kidney injury
- Allergic reactions
- Suicidal ideation (monitor mood changes)
How much does Zepbound cost?
Zepbound has the most aggressive cash-pay pricing of any branded GLP-1 thanks to LillyDirect vials:
| Route | Typical cost |
|---|---|
| List price (pens) | ~$1,060 / month |
| LillyDirect vials (cash-pay) | $349 (2.5 mg) – $499 / month |
| With commercial insurance | $25–$100 / month copay (when covered) |
| Lilly savings card | As low as $25 / month (eligible plans) |
Prices vary by clinic, dose, and location — always confirm directly. See real local pricing on our clinic listings.
Frequently asked questions
Is Zepbound the strongest weight loss drug?
Among FDA-approved options, yes — its 20%+ trial averages top every other approved medication, and it beat Wegovy directly in SURMOUNT-5. Stronger candidates (like retatrutide) are still in trials and not available by prescription.
What are Zepbound vials and are they cheaper?
Single-dose vials sold through LillyDirect for cash-pay patients — same drug as the pens, you draw it up with a syringe. At $349–$499/month they cost roughly half of list price and became the go-to once compounded tirzepatide wound down.
Does insurance cover Zepbound?
Coverage is improving but patchy — many commercial plans cover it with prior authorization, others exclude weight loss drugs entirely. The 2024 sleep apnea approval opened a second coverage pathway for patients with OSA. If denied, LillyDirect vials are the fallback.
How quickly does Zepbound work?
Appetite effects start within days of the first injection; measurable weight loss typically shows in the first month. Trial curves keep dropping through week 60+ as doses titrate up, so full results take a year or more.
Related medications
This page is for educational purposes only and is not medical advice. Zepbound is a prescription medication — talk to a licensed healthcare provider about whether it is right for you. GLPFinders is a directory service and does not prescribe, sell, or dispense medications.